An in-body networking system allows communication between wearable and implantable therapeutics using signals transmitted through the body's own tissues.

Transforming one-off therapies into accessible and repeatable programs requires early strategy and shared infrastructure.

Gut microbiome development in children at high genetic risk of type 1 diabetes follows three distinct maturation patterns ...

EASD 2026 findings show cancer incidence remains higher in people with type 2 diabetes, with the gap widening over 25 years, ...

Ultra-processed food is linked with multiple chronic disease outcomes with each 100g contributing to an increase in risk, a meta-analysis involving more than eight million people suggests.

Reduced bone density in the spine has been linked with poorer brain function, in research that could be particularly ...

A study looking at 920 chemicals linked to breast cancer risk shows many are ubiquitous in the environment and in many ...

Danegaptide could offer a new way to prevent or slow vision-threatening damage caused by diabetic retinopathy.

A new study reveals how an IL-21 mimic harnesses CD4 T cells to turn transient KRAS inhibitor responses into durable ...

Trial suggests vitamin C may have biological and clinical benefits for patients with pre-leukemia conditions and early ...

Beacon Therapeutics reports positive results in its Phase II/III trial of its gene therapy for treatment of X-linked retinitis pigmentosa.

A small prototype paper battery that eventually breaks down inside the body was functional for at least three days in a trial in pigs, report researchers from MIT. This is an early stage study, and ...